Of 122 deals involving pharmaceutical markets investigated over a five-year period, the FTC sought some kind of relief (such as a divestiture) in 119 of them.
FTC Report Shows Pharma Mergers Are Most Likely To Face Challenges
New Jersey Law Journal
January 4, 2013
This article requires premium access
This article requires premium access to The New Jersey Law Journal. Please sign in or subscribe to read the full text.